MapLight Therapeutics, Inc. (MPLT)

MapLight Therapeutics will go public soon. The estimated IPO date is October 28, 2025.

IPO Price

$17.00

Shares Offered

14,750,000

Deal Size

$250.75M

MapLight Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Market Capitalization	704	-	-
Enterprise Value	650	-	-
Debt / Equity Ratio	-0.03	-0.03	-0.05
Debt / EBITDA Ratio	-0.06	-0.08	-0.11
Debt / FCF Ratio	-0.06	-0.08	-0.11
Quick Ratio	4.04	6.83	5.43
Return on Equity (ROE)	37.72%	40.07%	47.38%
Return on Assets (ROA)	-	-56.66%	-60.94%
Return on Capital (ROIC)	40.98%	44.34%	51.30%
Return on Capital Employed (ROCE)	640.08%	-67.84%	-74.05%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).